FDA approval of mFLUSIVA highlights Moderna’s position in mRNA market
The FDA has approved Moderna’s messenger RNA (mRNA) seasonal influenza vaccine, mFLUSIVA (mRNA-1010), for the prevention of seasonal influenza in…
The FDA has approved Moderna’s messenger RNA (mRNA) seasonal influenza vaccine, mFLUSIVA (mRNA-1010), for the prevention of seasonal influenza in…
As populations age, the number of people living with mild cognitive impairment (MCI) and Alzheimer’s disease is expected to increase…
D&D Pharmaceuticals, a South Korean clinical-stage biopharmaceutical company focused on developing medicines for metabolic, fibrotic, and neurodegenerative diseases, has recently…
2026 marks a clear turning point for China’s position in the global clinical trials arena, particularly in oncology. At this…
GlobalData's Clinical Trials Database shows Alzheimer's disease pipeline activityconcentrated in early-phase trials, with Phase I and II together making up…
GlobalData's Clinical Trials Database shows the US leads global puberty suppression research with 25% of trials, as the Pathways trial's…
For decades, obesity has posed one of the most formidable threats to public health. Individuals living with obesity are at…
Loneliness, defined as a subjective experience of a discrepancy between the preferred interpersonal relationship an individual has and their actual…
Arrowhead Pharmaceuticals recently announced that the European Commission (EC) has granted marketing authorisation for Redemplo (plozasiran), an innovative apolipoprotein C…
According to the US Centers for Disease Control and Prevention (CDC), over 43,000 females and 4,000 females died from breast…